Power Metal Resources shares surge on completion of strategic funding round

Power Metal Resources shares surged on Thursday after the diversified junior miner announced a strategic funding round to accelerate exploration activities.

The funding round is notable because it was completed at a premium to the priors day’s closing day – a commendable feat in the current market, paying testament to the strength of the group’s underlying minerals portfolio.

Power Metal Resources raised £1.3 million through issuing 130 million new ordinary shares at 1.0 pence per share, a 3% premium to the prior closing price.

The financing was cornerstoned by UK high net worth investors and a strategic Saudi Arabian investor. Funds will be deployed to accelerate exploration initiatives and corporate activities across the Power Metal group.

The company has exploration assets focused on a wide range of minerals including uranium, gold, copper, lithium, and graphite, among others.

Power Metal Resources shares were 23% higher at 1.2p at the time of writing.

Shell shares rise after announcing bumper share buyback despite lower full-year earnings

Shell shares were higher in early trade on Thursday after the oil giant announced another bumper share buyback despite income and adjusted earnings sinking in 2023FY.

Lower oil prices were the main culprit in the falling adjusted earnings and revenue after Brent and WTI oil spent most of 2023 trading significantly beneath 2022 prices.

Shell shares were 2.3% higher at the time of writing on Thursday.

Adjusted EBITDA fell 19% to $68.5bn in 2023FY, and Adjusted Earnings fell 29% to $28.2bn.

However, Shell has again proved to be a cash-generation machine with a Free Cash Flow of $36bn. This is lower than last year but supports the company’s valuation, especially compared to US peers.

Shell will return cash to shareholders in the form of another $3.5bn share buyback and a $0.344 dividend for Q4 2023. The dividend increased from $0.331 in the last quarter.

As expected, the integrated gas unit was Shell’s powerhouse, with a strong performance in the fourth quarter, helping contain overall earnings decline in the unit for the full year.

Upstream, Shell’s largest unit concerned with oil extraction, fared better than some may have feared, with Adjusted Earnings growing 7% to $7.9bn in Q4. Upstream Adjusted EBITDA for the full year fell 27%.

The renewables unit still remains a sideshow for Shell, and Adjusted Earnings fell 60% in the full year.

The First FTSE AIM IPO of 2024 with MicroSalt’s Rick Guiney

The UK Investor Magazine was delighted to speak with Rick Guiney, CEO of MicroSalt plc, on the low-sodium technology company’s first day of dealing on London’s AIM.

MicroSalt are the first company to be listed on London’s AIM in 2024.

Rick details the health crisis associated with high-sodium consumption and how MicroSalt’s low-sodium technology can help prevent premature deaths.

The World Health Organisation estimates £1.8m die each year due to the overconsumption of salt.

MicroSalt is working with some of the world’s largest food companies to reformulate recipe ingredients to reduce sodium content using MicroSalt technology.

FTSE 100 stable ahead of Federal Reserve interest rate decision, GSK jumps

UK stocks shook off the impact of disappointment surrounding big US tech earnings overnight and carved out minor gains on Wednesday ahead of the Federal Reserve Interest Rate decision this evening.

The FTSE 100 was up 0.3% at the time of writing and could become choppier as the session progresses.

Tonight’s announcement should be considered a high volatility event, not because of any changes in rates, but rather the press conference and comments on the trajectory of rates.

“Investors may be sitting on their hands as they await the latest decision from the Federal Reserve – a first interest rate cut hasn’t been pegged any earlier than March so all the focus will be on the messaging which accompanies the announcement,” said AJ Bell investment director Russ Mould.

“The Fed may encourage the recent scaling back of rate cut expectations and the extent to which it does could determine the path markets forge over the coming weeks.”

In addition to tonight’s Federal Reserve decision, traders were reacting to results from major tech companies, including Alphabet and Microsoft.

Expectations were huge going into results, and although both companies beat analyst forecasts, they did not beat to the degree some had been hoping for.

Microsoft was trading down 0.8% as Alphabet slid 5% at the time of writing.

GSK

In the UK, GSK reported a solid set of full-year results, sending shares higher by 3%. The company has been frustratingly range-bound and while the current update may not be the catalyst for this range to break to the upside, it does provide support for shares to trend to the top end of the range.

“GlaxoSmithKline (GSK) reported full year and fourth quarter results that look well up with analyst forecasts. Strip out the impact of falling Covid-related sales and underlying revenue growth for the full year and final quarter was 14% and 17% respectively,” said Steve Clayton, head of equity funds, Hargreaves Lansdown.

“GSK sound confident in their statement, highlighting 71 Vaccines and Specialty Medicines now in clinical development, 18 of which have made it as far as phase III trials or beyond. Guidance for the coming year is for earnings growth of 6-9%, with a total dividend of 60p, up from 58p in the year just ended.”

Harbour Energy was the top faller after Goldman Sachs cut the shares to ‘sell’. Harbour Energy shares were down 5% at the time of writing.

AIM movers: Serabi Gold extends trial mining licence and Symphony Environmental loses EU court case

1

Serabi Gold (LON: SRB) has renewed its trial mining licence at the Coringa mine in Brazil for three years. This allows 50,000 tonnes of ore to be processed at the company’s Palito Complex each year. In 2024, gold production is expected to grow from 33,153 ounces to 40,000 ounces. Coringa could end up producing 30-35,000 ounces of gold each year. The share price has been rising all morning and is 29.5% ahead at 50.5p. That is the highest level since April 2022.

There was 25.5% share price increase to 10.35p following a trading statement by broadcast software Pebble Beach Systems (LON: PEB). The 2024 revenues were slightly higher than expected at £12.4m and net debt continues to fall, reaching £4.8m at the end of 2023. However, pre-tax profit has been downgraded from £1.7m to £1.6m by Cavendish.

Electrolyser technology developer ITM Power (LON: ITM) increased interim revenues from £2m to £8.9m, while the loss was reduced by more than two-thirds to £18.2m partly due to additional interest income. There was a £27.5m outflow from operating activities and cash was £253.7m at the end of October 2023. Management says that short-term economic concerns are slowing down the growth of the green hydrogen market. The share price is 24.6% higher at 59.68p.

Drilling contractors are on site at the Molopo Farms Complex, where Power Metal Resources (LON: POW) owns 87.7%, and drilling on a priority target will start in the next few days. This is a PGEs and nickel project. The share price increased 17.7% to 1p.

FALLERS

Symphony Environmental Technologies (LON: SYM) has failed to get the EU court to declare EU legislation invalid. This legislation relates to the d2w biodegradable technology, which is not included in the single-use plastic directive and the company says that this has hampered the take-up of the technology. The share price dived 48% to 3.25p, which is the lowest it has been for more than one decade.

Respiration equipment supplier Inspiration Healthcare (LON: IHC) had a poor fourth quarter and full year revenues will be £6m lower than expected at £37m, down from £41m the previous year. That will result in a full year loss. Net debt is higher than anticipated at £6.4m. There were contract delays for neonatal products. This business should happen in 2024-25 and a rebound to a pre-tax profit of £2.9m is forecast, although that is lower than the previous estimate of £4.7m. The share price slumped 24.3% to 40.5p.

The operator of the Duyung PSC, where Empyrean Energy (LON: EME) has a 8.5% interest, says that the capital costs of the first phase of the Mako gas project will cost $325m. It could cost $250m to get to first revenues. Further efficiencies could reduce the figures. The final investment decision has been delayed to the middle of 2024. Shares in Empyrean Energy fell 14.8% to 0.3195p. Coro Energy (LON: CORO) has a 15% interest in the Duyung PSC and the share price declined 12.2% to 0.165p.   

Graphene technology developer Directa Plus (LON: DCTA) has renewed its contract with Romanian automotive business FORD Otosan. The contract is for waste disposal and recycling services and it is worth €1.9m – 46% increase on the original contract in 2020 – and it will be recognised in 2024. That is more than 10% of forecast revenues of €17.7m. The share price slid 109% to 20.5p, which is an all-time low.

Microsoft and Alphabet deal markets a reality check as shares dip after earnings

Microsoft and Alphabet dealt equity traders a reality check last night after the two technology giants reported earnings overnight.

Shares in the two companies were slightly lower in the US premarket, not because the companies dramatically missed estimates – they both beat earnings forecasts – but because they didn’t beat to the extent that justifies the already frothy valuations expanding further.

Expectations were huge going into results, and there was a feeling that both companies needed to smash estimates out of the park to sustain a rally. This failed to materialise, and Microsoft was down 1.3%, while Google-owner Alphabet dipped 5.3% in US premarket trade.

Microsoft

Microsoft is investing heavily in AI, and its cloud business showed signs of strength in the cloud business, which was instrumental in driving the earnings beat.

Microsoft’s Q3 revenue came in at $62.02 billion, beating expectations of $61.12 billion. EPS was $2.93 per share, a decent best of the forecasted $2.78 per share.

“Microsoft’s numbers actually beat analysts’ forecasts, but their future guidance was not enough,” said Steve Clayton, head of equity funds at Hargreaves Lansdown.

A cloudy outlook coupled with questions about the effectiveness of investment in AI returning future earnings growth dragged on shares.

“The market has been caught up in the exciting potential around AI but it has largely neglected to consider the costs required to exploit this potential until now,” said AJ Bell investment director Russ Mould.

“Microsoft’s latest earnings update flagged substantial investment as it looks to roll out AI across all areas of its business. There is no doubt this is the right move for Microsoft; investing in the business seems a much better use of its capital from an investor perspective than buying back shares, for example.

“Where the market will be closely scrutinising Microsoft is in how efficiently this money gets spent. Any sense the company is just throwing cash at AI willy-nilly and hoping some of it pays off would not go down too well. 

“Quarterly numbers came in ahead of expectations with strong growth in its cloud division as customers lap up a suite of services which have been augmented using AI.”

Alphabet

While there was quiet discontent with Microsoft’s earnings, investors were evidently disappointed with Alphabet’s results. Earnings and revenue did beat estimates, but only marginally.

Advertising sales growth was much lower than expected, which would have unnerved the market.

The move higher in the stock in the run-up to results suggested traders expected fireworks from Alphabet and felt let down when the numbers hit the wires.

“Last time it was the cloud computing arm causing a downpour on Alphabet’s results, now it is the advertising segment which has made investors switch off. Analysts had high hopes for Alphabet-owned Google and YouTube to scoop up bucket loads of cash from advertising but the group has fallen short of what was expected,” Russ Mould said.

“When you’ve been so successful in the past, expectations can be high and this is certainly the case for all of the Magnificent Seven group of stocks. Everyone expects these companies to pull a rabbit out of the hat every time they report and the slightest miss causes widespread disappointment, even if the actual numbers still showed positive gains on comparative periods.”

UK house prices rise at the fastest pace in a year according to Nationwide

The average UK house price grew at the fastest pace in a year in January according to data released today by Nationwide.

The price of an average UK home grew 0.7% in the month of January to £257,656.

“UK house prices rose by 0.7% in January, after taking account of seasonal effects. This resulted in an improvement in the annual rate of house price growth from -1.8% in December to -0.2% in January, the strongest outturn since January 2023,” said Robert Gardner, Nationwide’s Chief Economist.

Gardner continued to explain falling mortgage rates were a core driver in the recent tick-up in house prices.

“There have been some encouraging signs for potential buyers recently with mortgage rates continuing to trend down. This follows a shift in view amongst investors around the future path of Bank Rate, with investors becoming more optimistic that the Bank of England will lower rates in the years ahead,” Gardner said.

Property experts are confident today’s news could mark the beginning of a recovery and the outlook for the market is in a much better place than it has been in recent months.

“Today’s data shows that the property sector is beginning to show signs of recovery. With a decline in inflation YoY and the peaking of interest rates, the overall outlook has considerably improved,” said Daniel Austin, CEO and co-founder at ASK Partners,” said

Reducing sodium consumption and cardiovascular disease with MicroSalt’s Judith Batchelar OBE

The UK Investor Magazine was delighted to welcome Judith Batchelar OBE, Non-Executive Chair of MicroSalt, for a fascinating conversation focused on reducing sodium intake, the health benefits of doing so, and the regulatory environment supporting action on salt.

Judith started her career in biochemistry before spending 35 years in the food and food retail industry, serving as a director of Sainsbury and Safeway and in senior roles at Marks & Spencer. Judith is a Fellow of the Institute of Food Science and Technology and the President of the British Nutrition Foundation.

Our discussion is dedicated to the millions of people who die prematurely each year from cardiovascular diseases and the actions undertaken by governments and businesses to help fight the overconsumption of sodium.

The World Health Organisation has recently released research concluding every $1 spent reducing sodium intake can save $12 in healthcare costs treating people impacted by cardiovascular disease.

MicroSalt has developed a low-sodium salt technology that reduces sodium in salt by up to 50% and has inked agreements with one of the world’s largest snack food companies, among many others.

Why companies left AIM in December 2023

There were nine companies that left AIM in December, while Afentra (LON: AFRN) was readmitted after a reverse takeover. Four companies were the subject of bids, two are being wound up and the other three got into financial difficulties. There were two new admissions during the month (Chapel Down (LON: CDGP) from Aquis Stock Exchange and Dial Square Investments from the standard list), the first for more than two months.
8 December
Actual Experience
Actual Experience is an analytics as a service business that uses software developed by Queen Mary’s University of London to help clients improve t...

AIM movers: Great Western Mining soil anomalies and Argentex falls short

3

Further good news from Great Western Mining Corporation (LON: GWMO) with positive soil and grab results at the West Huntoon copper project in Nevada. Management describes “strong gold and copper grades and bonanza silver grades”. There are also elevated molybdenum levels. Drilling targets are being chosen. The share price is two-fifths higher at 0.07p.

Trading has recommenced in Location Sciences (LON: LSAI) shares after the publication of readmission document for the proposed acquisition of Sorted Holdings for nominal consideration and the assumption of £4.7m of debt. Sorted Group has developed delivery software for ecommerce businesses. There will be a one-for-625 share consolidation and £2m will be raised at 87.5p/share. The company’s name will be changed to Sorted Group Holdings. The pre-consolidation share price rose 21.4% to 0.17p – the placing price is the equivalent of 0.14p.

Transport management software provider Microlise (LON: SAAS) did better than expected in 2023 and this has sparked upgrades for 2024. Full year revenues were 13% higher at £71.6m with annualised recurring revenues 11% ahead at £47.2m – churn rates are low. Pre-tax profit is estimated to have improved from £4.9m to £5.5m. In 2024, it could reach £6.7m. Microlise completed the acquisition of Enterprise Software Systems earlier this month. The share price has been in decline, but it recovered 20.1% to 122.5p.

Tekcapital (LON: TEK) shares have risen on the back of the AIM flotation of investee company MicroSalt on Thursday. MicroSalt should have a market capitalisation of £18.5m at 43p/share. Tekcapital is currently majority shareholder in MicroSalt and it will retain a large stake after participating in the placing prior to the flotation.  The share price improved 21.9% to 9.75p, which is the highest it has been since October.

FALLERS

Currency and payment services provider Argentex (LON: AGFX) will report lower than expected revenues and operating profit for 2023. The figures were expected to be similar to 2022, but revenues are down from £50.4m to approximately £49.8m, while operating profit will be around 30% lower at a minimum of £8m. Additional costs were in place to take advantage of anticipated growth that did not happen. Guy Rudolph has been appointed interim finance director and he will be seeking to reduce costs and improve efficiency. The share price has fallen 17.3% to a new low of 57.9p.

Allergy Therapeutics (LON: AGY) shares returned from suspension following the publication of the latest accounts for the year to June 2023. Revenues have been reduced by £1.4m to £59.6m since the preliminary results due to a reduction in expected statutory rebates in Germany. An £11.3m exceptional charge has been removed following the share issue after the year end. The share price slid 16% to 2.1p. ZQ Capital Management made a mandatory offer of 1p/share last year.

Shares in eyewear manufacturer Inspecs (LON: SPEC) continues to decline following the trading statement on Monday admitting that the improvement in profit in 2023 was not as great as expected because of weak December trading. EBITDA is likely to rise from £15.5m to £18m, whereas £20m was the consensus forecast. The full year results will be published on 17 April. The share price dipped a further 7.32% to 57p.

Engineering products distributor Flowtech Fluidpower (LON: FLO) says 2023 trading was as expected, but it is cautious about the current year. Operating profit fell from £8.6m to £6m in 2023. Although a recovery is anticipated this year it will be much less than previously thought. Liberum has cut its operating profit forecast from £9.8m to £7.1m even though the revenues figure is being maintained. A greater recovery is expected in 2025 as margins continue to improve. The share price slipped 4.68% to 75.3p, although that is higher than earlier in the day.